REFINE special issue

Drug Deliv Transl Res. 2022 Sep;12(9):2039-2041. doi: 10.1007/s13346-022-01209-3. Epub 2022 Jul 26.

Kathleen Spring¹, Klaus-M Weltring¹, Adriele Prina-Mello^{2

3

4}, Ruth Schmid⁵

¹ Gesellschaft fuer Bioanalytik Muenster e.V, Muenster, Germany.
² Nanomedicine and Molecular Imaging Group, Clinical Medicine, Trinity Translational Medicine Institute (TTMI), Trinity College Dublin, St James's Hospital, Dublin 8, Dublin, Ireland.
³ Laboratory for Biological Characterization of Advanced Materials (LBCAM), Trinity College Dublin, Dublin 8, Dublin, Ireland.
⁴ Trinity St James's Cancer Institute, Trinity College Dublin, St James's Hospital, Dublin 8, Dublin, Ireland.
⁵ Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway. ruth.b.schmid@sintef.no.

No abstract available

Publication types